期刊文献+

特利加压素治疗难治性感染性休克患者的临床效果 被引量:2

Clinical effect of terlipressin on treating patients with intractable septic shock
下载PDF
导出
摘要 目的探讨特利加压素对难治性感染性休克患者心指数、外周循环阻力的影响。方法选取我院2011年1月-2014年1月收治入院的感染性休克患者作为研究对象,所有患者给予积极体液复苏并使用大剂量去甲肾上腺素治疗,其中88例感染性休克患者循环仍难以维持,临床给于加用特利加压素(125μg/h),观察患者治疗前后平均动脉压、脉搏、心指数、外周循环阻力指数、尿量、血肌酐、尿素氮等指标。结果患者治疗后6、12、24、48 h MAP、SVRI均明显高于治疗前,而HR、CI等指标治疗后12、24、48 h明显低于治疗前,去甲肾上腺素用量明显低于治疗前,差异有统计学意义(P〈0.05);治疗后第1、3、7天尿量明显高于治疗前,而血肌酐、尿素氮在治疗后第3、7天时明显低于治疗前,差异均有统计学意义(P〈0.05)。结论特利加压素应用于难治性感染性休克能够改善心指数和外周循环阻力,临床效果显著,可在临床广泛推广。 Objective To explore the influence of terlipressin on cardiac index and peripheral vascular resistance in patients with intractable septic shock. Methods From January 2011 to January 2014,patients with septic shock treated and admitted into our hospital were selected as research objects.All patients were positively provided with fluid resuscitation and high dosage of norepinephrine for treatment.Among them,there were 88 septic shock patients whose circulation was hard to maintain,and 125 μg/h terlipressin was added in clinic.Mean arterial pressure(MAP),heart rate(HR),cardiac index(CI),index of systemic vascular resistance(SVRI),urine volume,serum creatinine,and urea nitrogen before and after treatment were observed. Results MAP and SVRI 6,12,24,and 48 hours after treatment were much higher than those before treatment,and HR and CI 12,24,and 48 hours after treatment were greatly lower than those before treatment.The dosage of norepinephrine used was obviously lower than that before adding norepinephrine,which all displayed statistical difference(P〈0.05).1,3,and 7 days after therapy,volume of urine was much more than that before,and serum creatinine,blood urea nitrogen 3 and 7 days after treatment were much lower than those before treatment with statistical difference(P〈0.05). Conclusion Additional application of terlipressin to treat intractable septic shock can improve CI and SVRI in a remarkable clinical effect,which is worthy of expansive promotion in clinic.
出处 《中国当代医药》 2016年第5期116-118,共3页 China Modern Medicine
关键词 感染性休克 特利加压素 二氧化碳分压 多巴胺 Septic shock Terlipressin Carbon dioxide partial pressure Dopamine
  • 相关文献

参考文献17

  • 1于浩天,陈莉萍.低剂量持续泵入特立加压素对感染性休克患者血流动力学的影响[J].华南国防医学杂志,2010,24(2):104-106. 被引量:4
  • 2郑永科,刘长文,朱克毅,陆俊,胡炜.特利加压素在脓毒血症难治性休克中的应用价值[J].浙江临床医学,2007,9(4):455-456. 被引量:7
  • 3RP Dellinger,JM Carlet,H Maswr,et al.Surviving sepsis campaign guidelines for management of severe sepsis and septic shock[J].Crit Care Med, 2004,32(4) : 536-555.
  • 4Delmas A, Leone M, Roussea S, et aLClinical review : Va- sopressin and trelipressin in septic shock patients[J].Crit Care, 2005,9 (2) : 212-222.
  • 5Matok L,Vard A,Efrati O,et al.Terlipressin as rescue threapy for intractable hypotension due to septic shock in children[J].Shock, 2005,23 (4) : 305 -310.
  • 6Scharte M,Meyer J,Van Aken H,et al.Hemodynamic ef- fects of terlipressin (a synthetic analog of vasopressin) in healthy and endotoxemic sheep[J].Crit Care Med,2001,29 (9) : 1756-1760.
  • 7Westphal M, Stubbe H, Sielenkamper AW, e t a/.Terlipressin dose response in healthy and endotoxemic sheep:impact on cardiopulmonary performance and global oxygen trans- port[J].Intensive Care Med, 2003,29(2) : 30t-308.
  • 8O'Brien A, Clapp L, Singer M.Terlipressin for norepine- phrine-resistant septic shock[J].Lancet, 2002,359 (9313) : 1209-1210.
  • 9Gedeborg R,Silander HC,Ronne-Engstrom E,et al.Ad- verse effects of high-dose epinephrine on cerebral blood flow during experimental cardiopulmonary resuscitation[J]. Crit Care Med,2000,28(5) : 1423-1;430.
  • 10张晓勤,黄晓波,李春玲.特利加压素在难治性感染性休克中的应用效果观察[J].实用医院临床杂志,2014,11(4):208-209. 被引量:6

二级参考文献61

  • 1高景利,李晓岚,王爱田.比较多巴胺与去甲肾上腺素对感染性休克血流动力学和氧代谢的影响[J].疑难病杂志,2008,7(7):390-393. 被引量:10
  • 2邱海波,杨毅,刘松桥.《2004严重感染和感染性休克治疗指南》系列讲座(2) 严重感染和感染性休克的容量复苏和血管活性药物应用[J].中国危重病急救医学,2004,16(8):451-453. 被引量:110
  • 3Delmas A,Leone M,Rousseau S,et al.Clinical review:Vasopressin and terlipressin in septic shock patients[J].Crit Care,2005,9(2):212-222.
  • 4Westphal M,Stubbe H,Sielenkmper AW,et al.Terlipressin dose response in healthy and endotoxemic sheep:impact on cardiopulmonary performance and global oxygen transport[J].Intensive Care Med,2003,29(2):301-308.
  • 5Ertmer C,Rehberg S,Morelli A,et al.Current place of vasopressin analogues in the treatment of septic shock[J].Curr Infect Dis Rep,2008,10(5):362-367.
  • 6Morelli A,Ertmer C,Rehberg S,et al.Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP):a randomized,controlled pilot study[J].Crit Care,2009,13(4):R130.
  • 7Matok I,Vard A,Efrati O,et al.Terlipressin as rescue therapy for intractable hypotension due to septic shock in children[J].Shock,2005,23(4):305-310.
  • 8Bracco D,Dubois MJ.Hemodynamic support in septic shock:is restoring a normal blood pressure the right target?[J].Crit Care Med,2005,33(9):2113-2115.
  • 9Phillinger RD,Carlet JM,Maswr H,et al.Surviving sepsis campaign guidelines for management of severe sepsis and septic shock.Crit Care Med,2004,32(3):858 ~ 872.
  • 10Delmas A,Leone M,Roussea S,et al.Clinical review:vasopressin and trelipressin in septic shock patients.Crit Care Med,2005,33 (2):373 ~380.

共引文献141

同被引文献24

引证文献2

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部